2-Amino-4,5,6,7,8,9-hexahydrocycloocta[b]-thiophene-3-carboxylic acid methyl ester, 95.0%, 1g

Diapositiva de contraste de fase con anillos de fase para objetivos de fase de plan de aceite PLPH 20x y S100x

IMPERATORIN, 95%, 1g

Aminoguanidine sulfate monohydrate, 97.0%, 500g

1-Fluoro-9H-carbazole, 95%, 10g

3-Chloro-2-methoxyisonicotinaldehyde, 95+%, 1g

Sulfonimidoyldibenzene, 97%, 1g

N-(6-methylidene-3-oxo-1,2,4-triazinan-4-yl)acetamide, 97%, 5g

2-Methylcyclohexanone>96.0%(GC)25mL

(1S)-1-(Pyrimidin-4-yl)ethan-1-ol, 95%, 250mg

trans,trans-4-(3,4-Difluorophenyl)-4'-vinylbicyclohexyl>98.0%(GC)1g

5-Methyl-2-aminobenzoxazol, 95.0%, 5g

(Cbz-4-Aminomethyl)piperidine, 95.0%, 1g